Recent Blog Articles
Improving access to hearing aids
Can mindfulness change your brain?
Five lifestyle factors that can help prevent gastroesophageal reflux disease
Transient ischemic attacks: Varied symptoms, all important
5 inflammation-fighting food swaps
Is IBD an underrecognized health problem in minority groups?
Sickle cell disease in newborns and children: What families should know and do
COVID-19 vaccines for children and teens: What we do — and don’t — know
Happy trails: Take a hike, now
Sleep well — and reduce your risk of dementia and death
Heart Beat: Generic ARBs are coming
People who take an angiotensin-receptor blocker (ARB) for high blood pressure or other reasons should soon be able to save some money on their medication. The FDA has given the go-ahead for losartan (Cozaar) to be sold as a generic drug. That makes losartan the first generic ARB on the market.
Angiotensin is a protein in the bloodstream that causes blood vessels to contract, which boosts blood pressure. ARBs work by preventing angiotensin from latching onto receptors in blood vessel walls, rendering it unable to deliver the "contract now" message that drives up blood pressure. They work as well as — but not usually better than — the older, less-expensive ACE inhibitors.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.